BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10073602)

  • 41. Structure of abnormal heavy chains in human heavy-chain-deposition disease.
    Khamlichi AA; Aucouturier P; Preud'homme JL; Cogné M
    Eur J Biochem; 1995 Apr; 229(1):54-60. PubMed ID: 7744049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometry.
    Royal V; Quint P; Leblanc M; LeBlanc R; Duncanson GF; Perrizo RL; Fervenza FC; Kurtin P; Sethi S
    J Am Soc Nephrol; 2015 Apr; 26(4):784-90. PubMed ID: 25194005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acquired cutis laxa associated with heavy chain deposition disease involving dermal elastic fibers.
    O'Malley JT; D'Agati VD; Sherman WH; Grossman ME
    JAMA Dermatol; 2014 Nov; 150(11):1192-6. PubMed ID: 25133950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
    Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K
    Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis.
    Gallo GR; Feiner HD; Katz LA; Feldman GM; Correa EB; Chuba JV; Buxbaum JN
    Am J Pathol; 1980 Jun; 99(3):621-44. PubMed ID: 6770693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein.
    Hendershot L; Bole D; Köhler G; Kearney JF
    J Cell Biol; 1987 Mar; 104(3):761-7. PubMed ID: 3102505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link?
    Husby G; Blichfeldt P; Brinch L; Brandtzaeg P; Mellbye OJ; Sletten K; Stenstad T
    Scand J Rheumatol; 1998; 27(4):257-64. PubMed ID: 9751465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heavy-chain deposition disease: a morphological, immunofluorescence and ultrastructural assessment.
    Rane S; Rana S; Mudrabettu C; Jha V; Joshi K
    Clin Kidney J; 2012 Oct; 5(5):383-9. PubMed ID: 26019812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Light-heavy chain deposition disease progressing to multiple myeloma.
    Daliani D; Weber D; Alexanian R
    Am J Hematol; 1995 Dec; 50(4):296-8. PubMed ID: 7485106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoproliferative small intestinal disease: a study of 13 cases with alpha heavy-chain disease.
    Price SK
    Histopathology; 1990 Jul; 17(1):7-17. PubMed ID: 2227833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
    Noel LH; Droz D; Ganeval D; Grunfeld JP
    Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Light chain nephropathy.
    Tubbs RR; Gephardt GN; McMahon JT; Hall PM; Valenzuela R; Vidt DG
    Am J Med; 1981 Aug; 71(2):263-9. PubMed ID: 6789678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal immunoglobin deposition disease, heavy chain deposition type.
    Fogo AB; Rossini M
    Am J Kidney Dis; 2003 Dec; 42(6):A48, E1-2. PubMed ID: 14655222
    [No Abstract]   [Full Text] [Related]  

  • 54. Use of bortezomib in heavy-chain deposition disease: a report of 3 cases.
    Patel K; Dillon JJ; Leung N; Bomback AS; Appel GB; D'Agati V; Canetta PA
    Am J Kidney Dis; 2014 Jul; 64(1):123-7. PubMed ID: 24613055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The value of immunofluorescence in the diagnosis of glomerulonephritis not related to systemic diseases.
    Morel-Maroger L; Adam C; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():81-110. PubMed ID: 4143636
    [No Abstract]   [Full Text] [Related]  

  • 56. Idiopathic nodular glomerulosclerosis.
    Herzenberg AM; Holden JK; Singh S; Magil AB
    Am J Kidney Dis; 1999 Sep; 34(3):560-4. PubMed ID: 10469869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoglobulin A Heavy Chain Deposition Disease: A Case Report.
    Chen Q; Ye JB; Zhong Q
    Iran J Kidney Dis; 2021 Dec; 15(6):457-460. PubMed ID: 34930858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudo-nonsecretory multiple myeloma with light chain deposition disease.
    Matsuzaki H; Yoshida M; Akahoshi Y; Kuwahara K; Satou T; Takatsuki K
    Acta Haematol; 1991; 85(3):164-8. PubMed ID: 1904181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resolution of nodular glomerular lesions in a patient with light-chain nephropathy.
    Hotta O; Taguma Y
    Nephron; 2002 Jul; 91(3):504-5. PubMed ID: 12119486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gamma heavy chain disease: clinical aspects and characterization of a deleted, noncovalently linked gamma1 heavy chain dimer (BAZ).
    Faguet GB; Barton BP; Smith LL; Garver FA
    Blood; 1977 Apr; 49(4):495-505. PubMed ID: 402960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.